Medicines Manufacturing Challenge Community Event 2021
31st March 2021 @ 10:00 am – 3:30 pm
2020 has called for rapid responses in the development, manufacture and supply of medicines. Now more than ever, the pressure is on to create strong, agile and sustainable medicines manufacturing infrastructure in the UK.
This Medicines Manufacturing Challenge Community showcase event, delivered by KTN is an opportunity to learn more about the latest projects and the research and infrastructure developments that will accelerate the development and manufacture of vital advanced therapies, medicines and vaccines.
In partnership with Innovate UK, the Medicines Manufacturing Innovation Centre and EPSRC Future Manufacturing Research Hubs, the event aims to enable this medicines manufacturing community to explore further opportunities for collaboration through networking across academia and industry.
This event will be a one-day, free-to-attend online event, featuring the following key agenda items:
- Introduction: Andy Jones, ISCF Medicines Manufacturing Challenge Director
- Opening Address: Steve Bagshaw, Fujifilm Diosynth Non-executive Chairman, Vaccine Task Force Supply Chain Lead
- Panel discussions on:
- Innovation infrastructure support (CPI, VMIC, MMIC, Cell and Gene Therapy Catapult)
- Net Zero in Medicines Manufacturing
- Equality, Diversity and Inclusion in Medicines Manufacturing
- Presentations from SME innovators
There will be networking time throughout the day as well as bookable 1-2-1 partnering meetings.
Networking – from 9am
Session 1 (10am – 1045am) – Medicines Manufacturing – New Directions, New Opportunities
Chair: Andy Jones
- Welcome – Andy Jones
- Key Note – Steve Bagshaw, Fujifilm Diosynth non-executive Chairman, Vaccine Task Force Supply Chain Lead
- Roadmapping Technology and Innovation for Medicines Manufacturing – Martin Wallace, Medicines Manufacturing Industry Partnership, and GSK
- Observations on the future (Andy Jones) and Q&A
Session 2 (11am – 12pm) – Supporting Industry with a Connected Innovation Infrastructure
Panel discussion involving audience Q&A
Chair: Sarah Goulding
- Lucy Foley – Director of Biologics, Centre for Process Innovation (CPI)
- Mathew Duchars – Chief Executive, Vaccine Manufacturing Innovation Centre (VMIC)
- Dave Tudor – Managing Director, Medicines Manufacturing Innovation Centre (MMIC)
- Stephen Ward – Chief Manufacturing Officer, Cell and Gene Therapy Catapult (C>C)
- Jen Vanderhoven, Director, National Horizon Centre, Teesside University
- Karen Wilkinson – Medicines Manufacturing Lead, KTN
Lunch break 12pm- 1:30pm (with 1:1 Networking between 12:30 and 1:30)
Session 3 – 1.30pm- 3.30pm Facilitated discussions, including Audience Q&A
- Bridging skills gaps through Equality, Diversity and Inclusion in the
Medicines Manufacturing sector, Chaired by Kate Barclay, BIA and Kate Barclay Consulting.
- What does Net Zero mean for Medicines Manufacturing? – Chair: Sheena Hindocha, KTN, followed by a short presentation on Industrial Energy Transformation Fund, by Jenni McDonnel, KTN.
Closing remarks and session close – Sarah Goulding
1:1 networking – open until 5.30pm